title: Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment.
authors.forename: Harpreet K
authors.initials: HK
authors.lastname: Lota
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Keir
authors.forename: David M
authors.initials: DM
authors.lastname: Hansell
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Nicholson
authors.forename: Toby M
authors.initials: TM
authors.lastname: Maher
authors.forename: Athol U
authors.initials: AU
authors.lastname: Wells
authors.forename: Elisabetta A
authors.initials: EA
authors.lastname: Renzoni
mesh_terms: D000542:Alveolitis, Extrinsic Allergic / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018951:Antigens, CD20; D001706:Biopsy; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008168:Lung / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D014797:Vital Capacity
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007155:Immunologic Factors; D000069283:Rituximab
keywords: Hypersensitivity pneumonitis; Interstitial Fibrosis